SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-044853
Filing Date
2021-02-16
Accepted
2021-02-16 16:06:06
Documents
1
Group Members
KEVIN STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP II, L.P.THIRD ROCK VENTURES GP III, L.P.THIRD ROCK VENTURES III, L.P.TRV GP II, LLCTRV GP III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d121350dsc13ga.htm SC 13G/A 197947
  Complete submission text file 0001193125-21-044853.txt   199731
Mailing Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures II, L.P. (Filed by) CIK: 0001488495 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89831 | Film No.: 21638106
SIC: 2836 Biological Products, (No Diagnostic Substances)